Get the Stockscreener App
0.38
0.00%
0.00
Alps Group Inc stock is traded at $0.38, with a volume of 48,642.
It is up +0.00% in the last 24 hours and down -4.14% over the past month.
ALPS Group Inc is a fully integrated platform encompassing biotechnology research, medical, and wellness services specializing in predictive, precision and preventive health management. It aims to provide its clientele with access to DNA and mRNA sequencing, cellular therapy, as well as wellness and anti-aging products and services.
See More
Previous Close:
$0.38
Open:
$0.371001
24h Volume:
48,642
Relative Volume:
0.47
Market Cap:
$63.23M
Revenue:
-
Net Income/Loss:
$-2.73M
P/E Ratio:
-0.5231
EPS:
-0.7265
Net Cash Flow:
$-962.40K
1W Performance:
-1.27%
1M Performance:
-4.14%
6M Performance:
-58.38%
1Y Performance:
+166.67%
1-Day Range:
$0.37
$0.38
1-Week Range:
$0.37
$0.3938
52-Week Range:
$0.2293
$2.90
Alps Group Inc Stock (ALPS) Company Profile
Compare ALPS vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALPS
Alps Group Inc
|
0.38 | 44.93M | 0 | -2.73M | -962.40K | -0.7265 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alps Group Inc Stock (ALPS) Latest News
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
ALPS (ALPS) Today: Posts a 1.48% Loss to $0.27 in Latest Trading; Support at $0.26 and Resistance at $0.28 Frame the RangeVWAP Deviation - vinanet.vn
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
ALPS Corporation Goes Live on OneShield Market Solutions to Power Lawyers' Professional Liability Operations for LawyerCare - Caledonian Record
The super-rich are building Swiss bunkers to stash their Ferraris, gold and fine wine - New York Post
The Alps, reimagined in Kapampangan Art - thevoicenewsweekly.com
INV Stock Price and Chart — NASDAQ:INV - TradingView
Alps Group Inc (ALPS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Alps Group Posts 44% Revenue Growth in FY2026 as Nasdaq‑Listed Biotech Sharpens Precision Medicine Focus - TipRanks
Alps Group Inc (Nasdaq: ALPS) grows FY 2026 revenue 44% to $4.9M - Stock Titan
ALPS Edges up on Quarterly Figures - Baystreet.ca
Alps Group's Revenue Reaches $4.9M as It Posts $2.1M Loss - Stock Titan
Buy 2 SS&C ALPS Mutual Funds for Risk-Adjusted Returns - Yahoo Finance
Alps Group Inc (ALPS) Stock News Today - TradingKey
Alps Group Inc (Nasdaq: ALPS) details 2026 20-F risks after SPAC - Stock Titan
Alps Group Inc Delays Annual 20-F Filing - TipRanks
Alps Group delays filing annual Form 20-F for fiscal 2026 - Bitget
TABLE-Alps Alpine -Q1 group results - TradingView
ALPS|Alps Group Inc|Price:0.415|Chg%:+0.000 - TradingKey
Alps Group Inc (ALPS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alps Group Inc (ALPS) Institutional Confidence - TradingKey
Alps Group Inc (ALPS) Cash Flow - TradingKey
Alps Group Inc (ALPS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
ALPS|Alps Group Inc|Price:0.320|Chg%:-0.008 - TradingKey
ALPS Group Inc (ALPS) Holds Near Support as Volume Suggests CautionSystematic Flow - dars.gov.et
Alps Group Inc (ALPS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alps Group Inc (ALPS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alps Group Inc (ALPS) Balance Sheet - TradingKey
ALPS|Alps Group Inc|Price:0.466|Chg%:-0.005 - TradingKey
ALPS Group Inc Revenue Breakdown – NASDAQ:ALPS - TradingView
NASDAQ(NASDAQ) Stock Price Today | Quotes & News - Moomoo
ELEPHAS ANNOUNCES COMMERCIAL PARTNERSHIP WITH INVITROCUE TO EXPAND PERSONALIZED ONCOLOGY IN SOUTHEAST ASIA - Yahoo Finance
Altesa BioSciences Welcomes Seasoned Biotech Leader Brett Haumann, MBBCh, MBA as Chief Executive Officer - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
I Thought a Group Hiking Trip Would Ruin the Magic of Traveling Alone—Then 47 Miles Through the Austrian Alps and Italian Dolomites Showed Me a New Side of Solo Travel - Travel + Leisure
Powell Industries, Inc. $POWL Shares Acquired by Principal Financial Group Inc. - MarketBeat
Western Midstream Partners, LP $WES Shares Bought by Catalyst Capital Advisors LLC - MarketBeat
Top movers in Friday's after hours session - ChartMill
Major Players and Competitive Dynamics in the Mountain and Snow Tourism Market - openPR.com
ETFs Investing in Alps Alpine Co., Ltd. Stocks - TradingView
ALPS Advisors Inc. Reduces Stake in Western Midstream Partners L - GuruFocus
ALPS Advisors Inc. Reduces Stake in Delek Logistics Partners LP - GuruFocus
ALPS Advisors Inc. Reduces Stake in Global Partners LP - GuruFocus
Familux Resorts Buys Two Properties to Expand Beyond the Alps - Yahoo Finance
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
ALPS-backed funds hold >22% of Hess Midstream (HESM) - Stock Titan
Malaysian firm sets sights on PHL healthcare market - BusinessMirror
Is ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) a Strong ETF Right Now? - Yahoo Finance
Why did Alps Group (ALPS) stock jump over 15% after hours? - MSN
ALPS PE Ratio & Valuation, Is ALPS Overvalued - Intellectia AI
Alps Group Inc Stock (ALPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):